Discover
HBIO
Harvard Bioscience, Inc.
6.05
2 x 4.47
2 x 7.75
bid
ask
-
0.10
1.63%
2 @ 04:00 PM
6.08 +0.03 (0.50%)
| Ytd | -9.70% | |
| 1y | 34.44% |
5.99
day range
6.28
3.80
52 week range
9.40
| Open | 6.15 | Prev Close | 6.15 | Low | 5.99 | High | 6.28 | Mkt Cap | 27.29M |
| Vol | 20.45K | Avg Vol | 40.25K | EPS | -2.15 | P/E | N/A | Forward P/E | 14.00 |
| Beta | 1.31 | Short Ratio | 2.66 | Inst. Own | 75.99% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 6.13 | 200-d Avg | 5.76 | 1yr Est | 6.25 |
| Income Statement | |||
| Total Revenue | 20.76M | ||
| Revenues (USD) | 20.76M | ||
| Cost of Revenue | 8.51M | ||
| Gross Profit | 12.24M | ||
| Operating Expenses | 13.42M | ||
| Research and Development Expense | 2.33M | ||
| Selling, General and Administrative Expense | 10.04M | ||
| Operating Income | -1.17M | ||
| Interest Expense | 1.73M | ||
| Income Tax Expense | 117.00K | ||
| Net Income | -3.42M | ||
| Net Income Common Stock | -3.42M | ||
| Net Income Common Stock (USD) | -3.42M | ||
| Consolidated Income | -3.42M | ||
| Earnings per Basic Share | -0.77 | ||
| Earnings per Basic Share (USD) | -0.77 | ||
| Earnings per Diluted Share | -0.77 | ||
| Earning Before Interest & Taxes (EBIT) | -1.58M | ||
| Earning Before Interest & Taxes (USD) | -1.58M | ||
| Weighted Average Shares | 4.47M | ||
| Weighted Average Shares Diluted | 4.47M | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.10M | ||
| Cash and Equivalents (USD) | 7.10M | ||
| Trade and Non-Trade Receivables | 14.57M | ||
| Current Assets | 47.48M | ||
| Property, Plant & Equipment Net | 11.60M | ||
| Total Assets | 77.94M | ||
| Total Debt | 42.57M | ||
| Current Liabilities | 23.86M | ||
| Debt Non-Current | 42.57M | ||
| Total Liabilities | 67.89M | ||
| Accumulated Retained Earnings (Deficit) | -218.13M | ||
| Accumulated Other Comprehensive Income | -12.31M | ||
| Shareholders Equity | 10.05M | ||
| Shareholders Equity (USD) | 10.05M | ||
| Assets Non-Current | 30.46M | ||
| Total Debt (USD) | 42.57M | ||
| Deferred Revenue | 3.67M | ||
| Goodwill and Intangible Assets | 16.28M | ||
| Inventory | 22.21M | ||
| Liabilities Non-Current | 44.03M | ||
| Trade and Non-Trade Payables | 5.29M | ||
| Tax Liabilities | 313.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.35M | ||
| Net Cash Flow from Financing | -9.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.52M | ||
| Capital Expenditure | -620.00K | ||
| Issuance (Purchase) of Equity Shares | 150.00K | ||
| Issuance (Repayment) of Debt Securities | -129.00K | ||
| Net Cash Flow from Investing | -620.00K | ||
| Net Cash Flow from Operations | -662.00K | ||
| Effect of Exchange Rate Changes on Cash | -225.00K | ||
| Share Based Compensation | 257.00K | ||